Table of contents

  1. Front Matter
    Pages i-xiv
  2. Diagnosis

    1. Front Matter
      Pages 1-1
    2. Brandon J. Manley, Gerald L. Andriole
      Pages 3-16
    3. Michael S. Leapman, Katsuto Shinohara
      Pages 53-67
    4. Nelson N. Stone, Vassilios M. Skouteris, E. David Crawford
      Pages 69-82
    5. Kevin Krughoff, Nelson N. Stone, Jesse Elliott, Craig Baer, Paul Arangua, E. David Crawford
      Pages 83-91
    6. Vassilios M. Skouteris, Spyros D. Yarmenitis, Georgios P. Zacharopoulos
      Pages 93-106
    7. Neal D. Shore, Karen Ventii
      Pages 127-137
  3. Treatment

    1. Front Matter
      Pages 139-139
    2. Kevin Krughoff, Al Barqawi
      Pages 153-166
    3. Michele Fascelli, Amichai Kilchevsky, Arvin K. George, Peter A. Pinto
      Pages 187-200
  4. Back Matter
    Pages 201-206

About this book


This comprehensive text provides a complete description of the newest technologies to diagnose and manage the most common prostate cancer diagnosed today: low risk disease. The book reviews new data about genetic markers, transperineal mapping biopsy and mpMRI, how to apply each of these technologies in patients with elevated PSA, when a prior prostate biopsy performed by the standard TRUS method is negative, and, in cases where low risk disease is already diagnosed, how to differentiate those men who might harbor more aggressive disease from those who do not. Over 75% of newly diagnosed prostate cancer meets the criteria for low risk disease which has created a dilemma for both patients and clinicians because of the inaccuracy of the standard TRUS biopsy method. Active surveillance programs have been initiated and are reviewed. How the new technologies impact surveillance programs are addressed. Clinical stage designation is updated and a new intra-prostatic staging system is discussed. Prostate biopsy techniques utilizing transrectal ultrasound, transperineal mapping, elastography and mpMRI are compared. Finally, utilization of these new technologies in the application of focal therapy is reviewed.      

The Prostate Cancer Dilemma will serve as a valuable resource for clinicians, surgeons and researchers with an interest in early prostate cancer. Chapters are written by experts in their fields and include the most up-to-date scientific and clinical information as well as links to procedural video content.


3D Biopsy Elastography Focal Cryoablation PSA TRUS biopsy mpMRI

Editors and affiliations

  • Nelson N. Stone
    • 1
  • E. David Crawford
    • 2
  1. 1.Department of Urology, The Icahn School of Medicine at Mount SinaiProfessor of Urology and Radiation OncologyNew YorkUSA
  2. 2.Radiation Oncology, University of Colorado, Denver Professor of Urology/SurgeryAuroraUSA

Bibliographic information

  • DOI
  • Copyright Information Springer International Publishing Switzerland 2016
  • Publisher Name Springer, Cham
  • eBook Packages Medicine Medicine (R0)
  • Print ISBN 978-3-319-21484-9
  • Online ISBN 978-3-319-21485-6
  • Buy this book on publisher's site